APA (7th ed.) Citation

Aditya Narayan, Shyam Srinivasan, Poonam Khemani, Nidhi Dhariwal, Akanksha Chichra, Chetan Dhamne, . . . Shripad Banavalli. (2024). Combination of low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical hodgkin lymphoma (rrhl), 5-year experience from tata memorial centre. Elsevier.

Chicago Style (17th ed.) Citation

Aditya Narayan, et al. Combination of Low-dose Nivolumab and Bendamustine in Children with High-risk Relapsed/refractory Classical Hodgkin Lymphoma (rrhl), 5-year Experience from Tata Memorial Centre. Elsevier, 2024.

MLA (9th ed.) Citation

Aditya Narayan, et al. Combination of Low-dose Nivolumab and Bendamustine in Children with High-risk Relapsed/refractory Classical Hodgkin Lymphoma (rrhl), 5-year Experience from Tata Memorial Centre. Elsevier, 2024.